Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy. [electronic resource]
Producer: 20011212Description: 3182-9 p. digitalISSN:- 0022-1767
- Adjuvants, Immunologic -- pharmacology
- Adoptive Transfer
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Arthritis, Experimental -- drug therapy
- Arthritis, Rheumatoid
- Autoimmune Diseases -- drug therapy
- B-Lymphocytes -- drug effects
- Cattle
- Cells, Cultured
- Collagen -- immunology
- Cytokines -- biosynthesis
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Enzyme Induction -- drug effects
- Immunoglobulin G -- biosynthesis
- Lymphocyte Count
- Male
- Matrix Metalloproteinase 2 -- biosynthesis
- Mice
- Mice, Inbred DBA
- Neuropeptides -- pharmacology
- Pituitary Adenylate Cyclase-Activating Polypeptide
- Synovial Membrane -- pathology
- T-Lymphocyte Subsets -- immunology
- T-Lymphocytes, Regulatory -- drug effects
- Th1 Cells -- drug effects
- Th2 Cells -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.